Julia Korell, Ph.D.

Principal Scientist II

Julia Korell brings over a decade of expertise in pharmacometrics, most recently serving as Executive Director and US Head of Pharmacometrics at Boehringer Ingelheim. In her 8 years there, she led efforts in model-informed drug development, contributing to key regulatory submissions and advancing pharmacometric practices.

Her diverse experience spans academia, consulting, and the pharmaceutical industry, where she is recognized for her leadership in quantitative decision-making and data-driven approaches to enhance clinical drug development. Julia holds a PhD in Pharmacometrics from the University of Otago and has completed a Certificate of Achievement in Immunology from Harvard Medical School’s HMX Pro program.